Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Francesca Marino, Salvatore D’Angelo, Ignazio Francesco Masala, Elisabetta Gerratana, Valeria Nucera, Laura La Corte, Manuela Giallanza, Piercarlo Sarzi-Puttini & Fabiola Atzeni. (2020) Toxicological considerations in the treatment of axial spondylo-arthritis. Expert Opinion on Drug Metabolism & Toxicology 16:8, pages 663-672.
Read now
Read now
Mitsumasa Kishimoto, Atsuo Taniguchi, Ayako Fujishige, Shuhei Kaneko, Sibylle Haemmerle, Brian O. Porter & Shigeto Kobayashi. (2020) Efficacy and safety of secukinumab in Japanese patients with active ankylosing spondylitis: 24-week results from an open-label phase 3 study (MEASURE 2-J). Modern Rheumatology 30:1, pages 132-140.
Read now
Read now
Articles from other publishers (33)
Mi Ryoung Seo, Jina Yeo, Jun Won Park, Yeon-Ah Lee, Ju Ho Lee, Eun Ha Kang, Seon Mi Ji, Seong-Ryul Kwon, Seong-Kyu Kim, Tae-Jong Kim, Tae-Hwan Kim, Hye Won Kim, Min-Chan Park, Kichul Shin, Sang-Hoon Lee, Eun Young Lee, Hoon Suk Cha, Seung Cheol Shim, Youngim Yoon, Seung Ho Lee, Jun Hong Lim & Han Joo Baek. (2023) Korean treatment recommendations for patients with axial spondyloarthritis. The Korean Journal of Internal Medicine 38:5, pages 620-640.
Crossref
Crossref
Danielle dos Reis Annunciato, Thauana Luiza Oliveira, Vanessa Oliveira Magalhães & Marcelo de Medeiros Pinheiro. (2023) Extra-musculoskeletal manifestations driving the therapeutic decision-making in patients with Spondyloarthritis: a 12-month follow-up prospective cohort study. Advances in Rheumatology 63:1.
Crossref
Crossref
Thomas J Kishen, Apoorv Kumar, Bhavana Girishekar & Vijay KR Rao. (2023) Incidence of Sacroiliitis among Patients Presenting with Chronic Low Back Pain to a Tertiary Care Spine Center. Journal of Orthopedics and Joint Surgery 5:2, pages 56-58.
Crossref
Crossref
Mi Ryoung Seo, Jina Yeo, Jun Won Park, Yeon-Ah Lee, Ju Ho Lee, Eun Ha Kang, Seon Mi Ji, Seong-Ryul Kwon, Seong-Kyu Kim, Tae-Jong Kim, Tae-Hwan Kim, Hye Won Kim, Min-Chan Park, Kichul Shin, Sang-Hoon Lee, Eun Young Lee, Hoon Suk Cha, Seung Cheol Shim, Youngim Yoon, Seung Ho Lee, Jun Hong Lim & Han Joo Baek. (2023) Korean treatment recommendations for patients with axial spondyloarthritis. Journal of Rheumatic Diseases 30:3, pages 151-169.
Crossref
Crossref
Jia Li, Zhixin Xue, Zhenbiao Wu, Liqi Bi, Huaxiang Liu, Lijun Wu, Shengyun Liu, Xiangyang Huang, Yong Wang, Yan Zhang, Wufang Qi, Lan He, Lie Dai, Lingyun Sun, Xiaomei Li, Zongwen Shuai, Yi Zhao, Yanyan Wang, Jian Xu, Hao Zhang, Hao Yu, Xiaoxiang Chen & Chunde Bao. (2022) Comparison of the efficacy and safety of the adalimumab biosimilar TQ-Z2301 and adalimumab for the treatment of Chinese patients with active ankylosing spondylitis: a multi-center, randomized, double-blind, phase III clinical trial. Clinical Rheumatology 41:10, pages 3005-3016.
Crossref
Crossref
Maria Llop, Jordi Gratacós, Mireia Moreno, Marta Arévalo, Joan Calvet, Maxime Dougados & Clementina López-Medina. (2022) Uveitis in peripheral spondyloarthritis patients: an ancillary analysis of the ASAS-PerSpA study. Therapeutic Advances in Musculoskeletal Disease 14, pages 1759720X2211192.
Crossref
Crossref
Lina M. Saldarriaga-Rivera, Wilson Bautista-Molano, Alejandro Junca-Ramírez, Andrés R. Fernández-Aldana, Daniel G. Fernández-Ávila, Diego A. Jaimes, Edwin A. Jáuregui, Juan S. Segura-Charry, Consuelo Romero-Sánchez & Oscar J. Felipe-Diaz. (2022) 2021 clinical practice guidelines for the diagnosis, treatment, and follow-up of patients with peripheral spondyloarthritis. Colombian Association of Rheumatology. Reumatología Clínica (English Edition) 18:1, pages 5-14.
Crossref
Crossref
Lina M. Saldarriaga-Rivera, Wilson Bautista-Molano, Alejandro Junca-Ramírez, Andrés R. Fernández-Aldana, Daniel G. Fernández-Ávila, Diego A. Jaimes, Edwin A. Jáuregui, Juan S. Segura-Charry, Consuelo Romero-Sánchez & Oscar J. Felipe-Diaz. (2022) Guía de práctica clínica 2021 para el diagnóstico, el tratamiento y el seguimiento de pacientes con espondiloartritis periférica. Asociación Colombiana de Reumatología. Reumatología Clínica 18:1, pages 5-14.
Crossref
Crossref
Lina M. Saldarriaga-Rivera, Wilson Bautista-Molano, Alejandro Junca-Ramírez, Andrés R. Fernández-Aldana, Daniel G. Fernández-Ávila, Diego A. Jaimes, Edwin A. Jáuregui, Juan S. Segura-Charry, Consuelo Romero-Sánchez & Oscar J. Felipe-Diaz. (2022) 2021 clinical practice guidelines for the diagnosis, treatment, and follow-up of patients with peripheral spondyloarthritis. Colombian Association of Rheumatology. Revista Colombiana de Reumatología (English Edition) 29:1, pages 44-56.
Crossref
Crossref
Lina M. Saldarriaga-Rivera, Wilson Bautista-Molano, Alejandro Junca-Ramírez, Andrés R. Fernández-Aldana, Daniel G. Fernández-Ávila, Diego A. Jaimes, Edwin A. Jáuregui, Juan S. Segura-Charry, Consuelo Romero-Sánchez & Oscar J. Felipe-Diaz. (2022) Guía de práctica clínica 2021 para el diagnóstico, el tratamiento y el seguimiento de pacientes con espondiloartritis periférica. Asociación Colombiana de Reumatología. Revista Colombiana de Reumatología 29:1, pages 44-56.
Crossref
Crossref
M. Manara, I. Prevete, A. Marchesoni, S. D'Angelo, A. Cauli, A. Zanetti, A. Ariani, A. Bortoluzzi, S. Parisi, C.A. Scirè & N. Ughi. (2021) The Italian Society for Rheumatology recommendations for the management of axial spondyloarthritis. Reumatismo 73:2, pages 71-88.
Crossref
Crossref
Xenofon Baraliakos, Filip Van den Bosch, Pedro M. Machado, Lianne S. Gensler, Helena Marzo-Ortega, Bintu Sherif, Erhard Quebe-Fehling, Brian Porter, Corine Gaillez & Atul Deodhar. (2020) Achievement of Remission Endpoints with Secukinumab Over 3 Years in Active Ankylosing Spondylitis: Pooled Analysis of Two Phase 3 Studies. Rheumatology and Therapy 8:1, pages 273-288.
Crossref
Crossref
Elsa How Shing Koy, Pierre Labauge, Athan Baillet, Clément Prati, Hubert Marotte & Yves-Marie Pers. (2021) Immunomodulation with IL-17 and TNF-α in spondyloarthritis: focus on the eye and the central nervous system. Therapeutic Advances in Musculoskeletal Disease 13, pages 1759720X2110258.
Crossref
Crossref
Mohammad H Derakhshan, Linda Dean, Gareth T Jones, Stefan Siebert & Karl Gaffney. (2020) Predictors of extra-articular manifestations in axial spondyloarthritis and their influence on TNF-inhibitor prescribing patterns: results from the British Society for Rheumatology Biologics Register in Ankylosing Spondylitis. RMD Open 6:2, pages e001206.
Crossref
Crossref
Uta Kiltz, Petros P. Sfikakis, Karl Gaffney, Paul-Gunther Sator, Ralph von Kiedrowski, Andreas Bounas, Nicola Gullick, Curdin Conrad, Dimitris Rigopoulos, Eric Lespessailles, Marco Romanelli, Pierre-Dominique Ghislain, Jan Brandt-Jürgens, Rasho Rashkov, Maher Aassi, Roberto Orsenigo, Chiara Perella, Effie Pournara, Sven Gathmann, Piotr Jagiello, Justyna Veit & Matthias Augustin. (2020) Secukinumab Use in Patients with Moderate to Severe Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis in Real-World Setting in Europe: Baseline Data from SERENA Study. Advances in Therapy 37:6, pages 2865-2883.
Crossref
Crossref
Iulia Rahela Marcu, Dalia Dop, Vlad Padureanu, Stefan Adrian Niculescu, Rodica Padureanu, Carmen Elena Niculescu & Otilia Constantina Rogoveanu. (2020) Non-Steroidal Anti-Inflammatory Drug Etoricoxib Facilitates the Application of Individualized Exercise Programs in Patients with Ankylosing Spondylitis. Medicina 56:6, pages 270.
Crossref
Crossref
Hakan Apaydin, Ismail Dogan & Şükran Erten. (2020) Secukinumab can treat psoriasis induced by anti‐TNF‐alpha therapy in patients with ankylosing spondylitis: Case series. International Journal of Rheumatic Diseases 23:3, pages 454-456.
Crossref
Crossref
Maxime Dougados, James Cheng-Chung Wei, Robert Landewé, Joachim Sieper, Xenofon Baraliakos, Filip Van den Bosch, Walter P Maksymowych, Joerg Ermann, Jessica A Walsh, Tetsuya Tomita, Atul Deodhar, Désirée van der Heijde, Xiaoqi Li, Fangyi Zhao, Clinton C Bertram, Gaia Gallo, Hilde Carlier & Lianne S Gensler. (2020) Efficacy and safety of ixekizumab through 52 weeks in two phase 3, randomised, controlled clinical trials in patients with active radiographic axial spondyloarthritis (COAST-V and COAST-W). Annals of the Rheumatic Diseases 79:2, pages 176-185.
Crossref
Crossref
Wojciech Tański, Natalia Świątoniowska-Lonc, Krzysztof Dudek & Beata Jankowska-Polańska. 2021. Best Practice in Health Care. Best Practice in Health Care
63
78
.
U. Kiltz, J. Braun, A. Becker, J.-F. Chenot, M. Dreimann, L. Hammel, A. Heiligenhaus, K.‑G. Hermann, R. Klett, D. Krause, K.‑F. Kreitner, U. Lange, A. Lauterbach, W. Mau, R. Mössner, U. Oberschelp, S. Philipp, U. Pleyer, M. Rudwaleit, E. Schneider, T. L. Schulte, J. Sieper, A. Stallmach, B. Swoboda & M. Winking. (2019) Langfassung zur S3-Leitlinie Axiale Spondyloarthritis inklusive Morbus Bechterew und Frühformen, Update 2019Long version on the S3 guidelines for axial spondyloarthritis including Bechterew’s disease and early forms, Update 2019. Zeitschrift für Rheumatologie 78:S1, pages 3-64.
Crossref
Crossref
Wei Zhu, Xuxia He, Kaiyuan Cheng, Linjie Zhang, Di Chen, Xiao Wang, Guixing Qiu, Xu Cao & Xisheng Weng. (2019) Ankylosing spondylitis: etiology, pathogenesis, and treatments. Bone Research 7:1.
Crossref
Crossref
Lai Shan Tam, James Cheng‐Chung Wei, Amita Aggarwal, Han Joo Baek, Peter P. Cheung, Praveena Chiowchanwisawakit, Leonila Dans, Jieruo Gu, Noboru Hagino, Mitsumasa Kishimoto, Heizel Manapat Reyes, Soosan Soroosh, Simon Stebbings, Samuel Whittle, Swan Sim Yeap & Chak Sing Lau. (2019) 2018 APLAR axial spondyloarthritis treatment recommendations. International Journal of Rheumatic Diseases 22:3, pages 340-356.
Crossref
Crossref
Ki-Jo Kim, Young Bin JooYune-Jung ParkKyung-Su Park. (2019) Association of Uveitis with Radiographic Progression in Patients with Axial Spondyloarthritis: A Propensity Score Matching Analysis. Journal of Rheumatic Diseases 26:4, pages 248.
Crossref
Crossref
Sonam Kiwalkar, James T. Rosenbaum, Sergio Schwartzman, Jan Peter Dutz & Filip Van den Bosch. 2019. Axial Spondyloarthritis. Axial Spondyloarthritis
157
182
.
Désirée van der Heijde, James Cheng-Chung Wei, Maxime Dougados, Philip Mease, Atul Deodhar, Walter P Maksymowych, Filip Van den Bosch, Joachim Sieper, Tetsuya Tomita, Robert Landewé, Fangyi Zhao, Eswar Krishnan, David H. Adams, Beth Pangallo, Hilde Carlier, Melvin Churchill, Kathleen Flint, Geoffrey Gladstein, Maria Greenwald, Mary Howell, Akgun Ince, Jeffrey Kaine, Daksha Mehta, Eric Peters, Roel Querubin, John Reveille, Richard Roseff, Roger Diegel, Christine Thai, Louis Bessette, Frederic Morin, Proton Rahman, Aaron Alejandro Barrera Rodriguez, Fidencio Cons-Molina, Sergio Duran Barragan, Cassandra Skinner, Cesar Pacheco Tena, Cesar Ramos Remus, Juan Cruz Rizo Rodriguez, Seung-Jae Hong, Yeon-Ah Lee, Ji Hyeon Ju, Seong Wook Kang, Tae-Hwan Kim, Chang Keun Lee, Eun Bong Lee, Sang Heon Lee, Min-Chan Park, Kichul Shin, Sang-Hoon Lee, Hung-An Chen, Ying-Chou Chen, Song-Chou Hsieh, Joung-Liang Lan, Zdenek Dvorak, Radka Moravcova, Martina Malcova, Yoshinori Taniguchi, Mitsumasa Kishimoto, Kurisu Tada, Hiroaki Dobashi, Kentaro Inui, Yukitaka Ueki, Yoshifuji Matsumoto, Yoshinobu Koyama, Kazuhiro Hatta, Tatsuya Atsumi, Hitoshi Goto, Kiyoshi Matsui, Yuya Takakubo, Gunther Neeck, Denis Poddubnyy, Andrea Rubbert-Roth, Malgorzata Szymanska, Tomasz Blicharski, Anna Dudek, Artur Racewicz, Rafal Wojciechowski, Marleen van de Sande, Ed Griep, Mike Nurmohamed, Galina Matsievskaya, Evgeniya Shmidt, Marina Stanislav, Sergey Yakushin, Olga Ershova, Andrey Rebrov, Tibor Balazs, Regina Cseuz, Edit Drescher & Gyula Poor. (2018) Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial. The Lancet 392:10163, pages 2441-2451.
Crossref
Crossref
Xiaoyong Lan, Haiping Ma, Zhiping Zhang, Dong Ye, Jun Min, Feng Cai & Jun Luo. (2018) Downregulation of lncRNA TUG1 is involved in ankylosing spondylitis and is related to disease activity and course of treatment. BioScience Trends 12:4, pages 389-394.
Crossref
Crossref
Jeong Seok Lee, Baek-Lok Oh, Hee Young Lee, Yeong Wook Song & Eun Young Lee. (2018) Comorbidity, disability, and healthcare expenditure of ankylosing spondylitis in Korea: A population-based study. PLOS ONE 13:2, pages e0192524.
Crossref
Crossref
Hai Lin & Yi-Zhen Gong. (2017) Association of HLA-B27 with ankylosing spondylitis and clinical features of the HLA-B27-associated ankylosing spondylitis: a meta-analysis. Rheumatology International 37:8, pages 1267-1280.
Crossref
Crossref
Joachim Sieper, Atul Deodhar, Helena Marzo-Ortega, Jacob A Aelion, Ricardo Blanco, Tseng Jui-Cheng, Mats Andersson, Brian Porter & Hanno B Richards. (2017) Secukinumab efficacy in anti-TNF-naive and anti-TNF-experienced subjects with active ankylosing spondylitis: results from the MEASURE 2 Study. Annals of the Rheumatic Diseases 76:3, pages 571-592.
Crossref
Crossref
Alfredo Manuel Adán-Civera, José Manuel Benítez-del-Castillo, Ricardo Blanco-Alonso, Esperanza Pato-Cour, Agustí Sellas-Fernández & Antonio Bañares-Cañizares. (2016) Burden and Direct Costs of Non Infectious Uveitis in Spain. Reumatología Clínica (English Edition) 12:4, pages 196-200.
Crossref
Crossref
Alfredo Manuel Adán-Civera, José Manuel Benítez-del-Castillo, Ricardo Blanco-Alonso, Esperanza Pato-Cour, Agustí Sellas-Fernández & Antonio Bañares-Cañizares. (2016) Carga y costes directos de la uveítis no infecciosa en España. Reumatología Clínica 12:4, pages 196-200.
Crossref
Crossref
Dominique Baeten, Joachim Sieper, Jürgen Braun, Xenofon Baraliakos, Maxime Dougados, Paul Emery, Atul Deodhar, Brian Porter, Ruvie Martin, Mats Andersson, Shephard Mpofu & Hanno B. Richards. (2015) Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis. New England Journal of Medicine 373:26, pages 2534-2548.
Crossref
Crossref
Muhammad A. Khan, Muhammad Haroon & James T. Rosenbaum. (2015) Acute Anterior Uveitis and Spondyloarthritis: More Than Meets the Eye. Current Rheumatology Reports 17:9.
Crossref
Crossref